- Home
- XHR vs IMTX Comparison
XHR vs IMTX Comparison
Compare XHR & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XHR | IMTX |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XHR | IMTX |
|---|---|---|
| Price | $16.01 | $11.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $15.67 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 702.4K | 273.8K |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ 326.67 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $1,078,500,000.00 | N/A |
| Revenue This Year | $3.94 | N/A |
| Revenue Next Year | $2.68 | $25.91 |
| P/E Ratio | $26.16 | ★ N/A |
| Revenue Growth | ★ 3.80 | N/A |
| 52 Week Low | $11.15 | $3.94 |
| 52 Week High | $17.23 | $12.41 |
Technical Indicators
Market Signals| Indicator | XHR | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.81 | 56.47 |
| Support Level | $14.26 | $9.61 |
| Resistance Level | $16.45 | $11.41 |
| Average True Range (ATR) | 0.43 | 0.42 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 15.65 | 52.53 |
Price Performance
Historical ComparisonAbout XHR Xenia Hotels & Resorts Inc.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other regions. Xenia's revenue is divided between the sale of rooms, food and beverages, and other sources.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.